Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-02-25

Clinical Trial Update: A Study of DU-176b in Preventing Blood Clots After Hip Replacement Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial update for DU-176b focused on preventing blood clots after hip replacement surgery; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DU-176b

Snippet

Sponsor: Daiichi Sankyo | Conditions: Thrombosis, Hip Replacement | Phase 2 | Status: COMPLETED | Results posted: 2015-02-25